Maximilian Hunt is a seasoned life sciences strategy consultant with extensive experience in global pricing, market access, and value positioning. He has worked with biopharmaceutical manufacturers at all stages of product development, providing strategic guidance for early stage due diligence, clinical study design, health technology assessment guidance, value proposition development, payer engagement strategy, pricing & contracting, innovative payment model design, patient access programs, and lifecycle management. With on the ground experience in both the U.S. and Europe, Max has targeted a wide range of commercial business issues related to pricing, access, and value, with a focus on pricing and market access strategy in the U.S., Europe, and other global markets. Max is committed to delivering innovative and impactful commercial strategy recommendations to biopharmaceutical manufacturers navigating the evolving global payer marketplace. His work has targeted a wide range of therapeutic areas, with particular emphasis on oncology, inflammatory conditions, and rare diseases, inclusive of work with emerging technologies such as cell and gene therapies. Max holds a Bachelor of Science degree from The Johns Hopkins University.